How is Burkitt lymphoma/Burkitt-like lymphoma (BL/BLL) staged?

Updated: Dec 20, 2019
  • Author: Ali H Kanbar, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

Patients with more than 25% bone marrow involvement are usually referred to as having Burkitt leukemia (BL). However, most patients will present with nodal or extranodal masses. Different staging systems, such as the National Cancer Institute (NCI) and Ann Arbor and St. Jude/Murphy staging systems, as well as a risk-adapted approach, have been proposed for these patients and are summarized below.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!